Yoshiharu Higuchi Selected Research

Yoshiharu Higuchi Research Topics

Disease

13	Heart Failure 01/2022 - 10/2004
11	Atrial Fibrillation 03/2022 - 04/2012
11	Myocardial Infarction 01/2022 - 08/2006
9	Hemorrhage 03/2022 - 01/2019
6	Thrombosis (Thrombus) 01/2022 - 01/2016
6	Hypertrophy 01/2008 - 01/2002
5	Cardiomegaly (Heart Hypertrophy) 05/2007 - 01/2002
4	Stroke (Strokes) 01/2022 - 04/2020
4	Embolism (Embolus) 12/2021 - 01/2018
4	Infections 02/2005 - 01/2002
3	Acute Coronary Syndrome 10/2021 - 09/2017
3	Neointima 08/2021 - 09/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
2	Chronic Renal Insufficiency 01/2022 - 12/2020
2	Inflammation (Inflammations) 07/2020 - 01/2020
2	Death (Near-Death Experience) 07/2020 - 01/2017
2	Ischemia 07/2020 - 02/2003
2	Hyperplasia 09/2017 - 01/2016
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2007 - 10/2004
2	Ventricular Remodeling 08/2006 - 12/2003
1	Body Weight (Weight, Body) 03/2022
1	Abdominal Obesity 01/2022
1	Peripheral Arterial Disease 01/2022
1	Obesity 01/2022
1	ST Elevation Myocardial Infarction 10/2021
1	Ulcer 10/2021
1	Constrictive Pericarditis 04/2021
1	Pericardial Effusion 04/2021
1	Adenocarcinoma of Lung 01/2021
1	Adenocarcinoma 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Torsades de Pointes (Torsade de Pointes) 01/2021
1	Cardiotoxicity 01/2021
1	Anemia 12/2020
1	Diabetes Mellitus 12/2020
1	Malnutrition (Nutritional Deficiencies) 07/2020
1	Prodromal Symptoms 01/2020
1	Syncope (Fainting) 01/2020
1	Aortic Dissection 01/2020
1	Atherosclerosis 09/2019
1	Ventricular Fibrillation 12/2018
1	Shock 12/2018
1	Tachycardia (Tachyarrhythmias) 12/2018
1	Hemothorax 01/2018
1	Aneurysm (Aneurysms) 01/2018
1	Stable Angina 01/2016
1	Rupture 10/2014
1	Unstable Angina 02/2013

Drug/Important Bio-Agent (IBA)

8	AnticoagulantsIBA 03/2022 - 01/2019
6	MAP Kinase Kinase Kinase 5IBA 01/2008 - 01/2002
4	Phosphotransferases (Kinase)IBA 07/2007 - 02/2003
4	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 02/2005 - 01/2002
4	NF-kappa B (NF-kB)IBA 02/2005 - 01/2002
3	Hemoglobins (Hemoglobin)IBA 03/2022 - 08/2008
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2017
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 08/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2002 - 01/2002
2	Prasugrel Hydrochloride FDA Link 01/2022 - 12/2020
2	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 07/2020
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2020 - 01/2019
2	C-Reactive ProteinIBA 07/2020 - 01/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2020 - 01/2019
2	MetalsIBA 09/2017 - 10/2014
2	Angiotensin IIIBA 10/2004 - 01/2002
2	Endothelin-1 (Endothelin 1)IBA 06/2004 - 01/2002
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2004 - 01/2002
2	NF-KappaB Inhibitor alphaIBA 06/2003 - 01/2002
1	CreatinineIBA 03/2022
1	Eplerenone (Inspra)FDA LinkGeneric 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2022
1	Everolimus FDA Link 12/2021
1	LipidsIBA 08/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	EnzymesIBA 01/2021
1	osimertinibIBA 01/2021
1	AlbuminsIBA 07/2020
1	Cholinesterases (Cholinesterase)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Arachidonic Acid (Vitamin F)IBA 11/2019
1	Eicosapentaenoic AcidIBA 11/2019
1	Thallium-201IBA 12/2018
1	BESIBA 09/2017
1	PotassiumIBA 08/2016
1	Fluspirilene (Imap)IBA 01/2016
1	Dobutamine FDA LinkGeneric 10/2010
1	Nicorandil (SG 75)IBA 05/2009

Therapy/Procedure

11	Stents 01/2022 - 10/2014
11	Therapeutics 01/2022 - 07/2007
7	Percutaneous Coronary Intervention 01/2022 - 02/2013
4	Drug-Eluting Stents 10/2021 - 01/2016
3	Catheter Ablation 11/2019 - 04/2012
2	Drug Tapering 01/2021 - 04/2020
1	Radiotherapy 01/2021
1	Patient Readmission 07/2020
1	Endovascular Aneurysm Repair 01/2020
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2018
1	Punctures 01/2018